Labcorp Holdings Inc. (LH) stock
LHNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3016% above fair value
$370.78+2.54 (+0.69%)
Close on Nov 18, 2026Market cap $30.11BP/E 30.4Yield 0.78%
Labcorp pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Labcorp's pe ratio was 30.7× on Nov 10, 2026, against 26.4× a year earlier. Over the last 5 years it ranged from 9.6× to 45.8×, with a median of 25.5×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 10, 2026 | 30.7× | +6.1 |
| 2025 | Dec 31, 2025 | 24.6× | −16.2 |
| 2024 | Dec 31, 2024 | 40.8× | +18.4 |
| 2023 | Dec 29, 2023 | 22.4× | +9.8 |
| 2022 | Dec 30, 2022 | 12.6× | +1.4 |
| 2021 | Dec 31, 2021 | 11.2× | −12.5 |
| 2020 | Dec 31, 2020 | 23.7× | +1.4 |
| 2019 | Dec 31, 2019 | 22.3× | +13.0 |
| 2018 | Dec 31, 2018 | 9.2× | −13.8 |
| 2017 | Dec 29, 2017 | 23.0× | +2.7 |
| 2016 | Dec 30, 2016 | 20.3× | −6.7 |
| 2015 | Dec 31, 2015 | 27.0× | +16.8 |
| 2014 | Dec 31, 2014 | 10.2× | −4.8 |
| 2013 | Dec 31, 2013 | 15.1× | +0.8 |
| 2012 | Dec 31, 2012 | 14.3× | −2.9 |
| 2011 | Dec 30, 2011 | 17.2× | +0.9 |
| 2010 | Dec 31, 2010 | 16.3× | +1.0 |
| 2009 | Dec 31, 2009 | 15.4× | – |
See a number that looks wrong?